Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
case report
Email alerts
case report
2022-RA-1287-ESGO Case report of a patient with relapsed ovarian cancer and therapy with all three approved PARP-inhibitors
Katharina Franziska
Keller
,
Elena Ioana
Braicu
,
Jacek P
Grabowski
,
Klaus
Pietzner
,
Jalid
Sehouli
International Journal of Gynecologic Cancer
Oct 2022,
32
(Suppl 2)
A317;
DOI:
10.1136/ijgc-2022-ESGO.677
A unique BRCA1 mutation identified in Mongolia
L.
Elit
,
E.
Jack
,
E.
Kwan
,
G.
Baigal
,
S.
Narod
International Journal of Gynecologic Cancer
May 2001,
11
(3)
241-243;
DOI:
10.1136/ijgc-00009577-200105000-00014
Special collections
Editor's choice
(187)
Guidelines, Recommendations and Consensus Statements
IJGC
Case Study
(17)
Cervical Cancer
(20)
Clinical Trial
(107)
Corners of the World
(23)
Endometrial Cancer
Fertility and Pregnancy
Lay summaries
(1)
Lead articles
(13)
Ovarian Cancer
(35)
Palliative Care
Perioperative Care
Preinvasive Disease
(1)
Review
(28)
Surgical Outcomes
Uterine Cancer
(16)
Video Article
(177)
Vulvar Cancer
(2)
Open access
(266)
Press releases
(4)